These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10935691)

  • 1. Effect of prenatal zidovudine on disease progression in perinatally HIV-1-infected infants.
    de Souza RS; Gómez-Marín O; Scott GB; Guasti S; O'Sullivan MJ; Oliveira RH; Mitchell CD
    J Acquir Immune Defic Syndr; 2000 Jun; 24(2):154-61. PubMed ID: 10935691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid disease progression in HIV-1 perinatally infected children born to mothers receiving zidovudine monotherapy during pregnancy. The Italian register for HIV Infection in Children.
    AIDS; 1999 May; 13(8):927-33. PubMed ID: 10371173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Siegfried N; van der Merwe L; Brocklehurst P; Sint TT
    Cochrane Database Syst Rev; 2011 Jul; (7):CD003510. PubMed ID: 21735394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection.
    Volmink J; Siegfried NL; van der Merwe L; Brocklehurst P
    Cochrane Database Syst Rev; 2007 Jan; (1):CD003510. PubMed ID: 17253490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.
    Peters V; Liu KL; Dominguez K; Frederick T; Melville S; Hsu HW; Ortiz I; Rakusan T; Gill B; Thomas P
    Pediatrics; 2003 May; 111(5 Pt 2):1186-91. PubMed ID: 12728136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovudine.
    Baroncelli S; Pinnetti C; Genovese O; Tamburrini E; Floridia M
    J Med Virol; 2011 Mar; 83(3):551-6. PubMed ID: 21264878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Estimate of HIV-1 infection prevalence in pregnant women and effectiveness of zidovudine administered during pregnancy in the prevention of vertical transmission].
    Ramos Amador JT; Contreras JR; Bastero R; Barrio C; Moreno P; Delgado R; Muñoz E; Jiménez J
    Med Clin (Barc); 2000 Mar; 114(8):286-91. PubMed ID: 10774515
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 genotypic zidovudine drug resistance and the risk of maternal--infant transmission in the women and infants transmission study. The Women and Infants Transmission Study Group.
    Welles SL; Pitt J; Colgrove R; McIntosh K; Chung PH; Colson A; Lockman S; Fowler MG; Hanson C; Landesman S; Moye J; Rich KC; Zorrilla C; Japour AJ
    AIDS; 2000 Feb; 14(3):263-71. PubMed ID: 10716502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of intensive nurse case management in decreasing vertical transmission of human immunodeficiency virus infection in Wisconsin.
    Havens PL; Cuene BE; Hand JR; Gern JE; Sullivan BW; Chusid MJ
    Pediatr Infect Dis J; 1997 Sep; 16(9):871-5. PubMed ID: 9306482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
    Taha TE; Kumwenda NI; Hoover DR; Fiscus SA; Kafulafula G; Nkhoma C; Nour S; Chen S; Liomba G; Miotti PG; Broadhead RL
    JAMA; 2004 Jul; 292(2):202-9. PubMed ID: 15249569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?
    Briand N; Warszawski J; Mandelbrot L; Dollfus C; Pannier E; Cravello L; Nguyen R; Matheron I; Winer N; Tubiana R; Rouzioux C; Faye A; Blanche S;
    Clin Infect Dis; 2013 Sep; 57(6):903-14. PubMed ID: 23728147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of immediate neonatal zidovudine on prevention of vertical transmission of human immunodeficiency virus type 1.
    Sirinavin S S; Phaupradit W; Taneepanichskul S; Atamasirikul K; Hetrakul P; Thakkinstian A; Panburana P
    Int J Infect Dis; 2000; 4(3):148-52. PubMed ID: 11179918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in perinatal transmission and mortality from human immunodeficiency virus after intervention with zidovudine in Barbados.
    St John AM; Kumar A; Cave C
    Pediatr Infect Dis J; 2003 May; 22(5):422-6. PubMed ID: 12792382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal and infant factors predicting disease progression in human immunodeficiency virus type 1-infected infants. Women and Infants Transmission Study Group.
    Rich KC; Fowler MG; Mofenson LM; Abboud R; Pitt J; Diaz C; Hanson IC; Cooper E; Mendez H
    Pediatrics; 2000 Jan; 105(1):e8. PubMed ID: 10617745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maternal immune responses and risk of infant infection with HIV-1 after a short course Zidovudine in a cohort of HIV-1 infected pregnant women in rural Kenya.
    Makokha EP; Songok EM; Orago AA; Koech DK; Chemtai AK; Kobayashi N; Mpoke S; Tukei PM; Andayi FA; Lihana RW; Adungo NI; Vulule JM
    East Afr Med J; 2002 Nov; 79(11):567-73. PubMed ID: 12630488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of the maternal-infant zidovudine regimen utilized in the Pediatric AIDS Clinical Trial Group 076 Study.
    Sperling RS; Shapiro DE; McSherry GD; Britto P; Cunningham BE; Culnane M; Coombs RW; Scott G; Van Dyke RB; Shearer WT; Jimenez E; Diaz C; Harrison DD; Delfraissy JF
    AIDS; 1998 Oct; 12(14):1805-13. PubMed ID: 9792381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short course zidovudine maternal treatment in HIV-1 vertical transmission: randomized controlled multicenter trial.
    Limpongsanurak S; Thaithumyanon P; Chaithongwongwatthana S; Thisyakorn U; Ruxrungtham K; Kongsin P; Tarounotai U; Chantheptaewan N; Triratwerapong T; Ubolyam S; Phanuphak P; Virutamasen P; Hanwanich M; Hawanon P; Chulasugondha P
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S338-45. PubMed ID: 11529355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal adherence to the zidovudine regimen for HIV-exposed infants to prevent HIV infection: a preliminary study.
    Demas PA; Webber MP; Schoenbaum EE; Weedon J; McWayne J; Enriquez E; Bamji M; Lambert G; Thea DM
    Pediatrics; 2002 Sep; 110(3):e35. PubMed ID: 12205285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of levels of maternal HIV-1 RNA associated with risk of perinatal transmission. Effect of maternal zidovudine treatment on viral load.
    Dickover RE; Garratty EM; Herman SA; Sim MS; Plaeger S; Boyer PJ; Keller M; Deveikis A; Stiehm ER; Bryson YJ
    JAMA; 1996 Feb; 275(8):599-605. PubMed ID: 8594240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.